Literature DB >> 30247981

MRI-Guided Cryoablation of Epidural Malignancies in the Spinal Canal Resulting in Neural Decompression and Regrowth of Bone.

Thomas C Lee1, Jeffrey P Guenette1, Ziev B Moses2, John H Chi2.   

Abstract

OBJECTIVE: The purpose of this article is to describe the use of MRI to safely monitor cryoablation for the treatment of spinal epidural malignancies.
CONCLUSION: Use of MRI guidance to monitor percutaneous cryoablation allows ablation margins more distinct than those allowed by heat-based ablation modalities. MRI-guided cryoablation is a feasible option for treating epidural tumors involving the spinal canal, resulting in successful decompression of the tumor away from the spinal cord with regrowth of previously eroded bone around the spinal canal.

Entities:  

Keywords:  cryosurgery; epidural neoplasms; interventional MRI; spinal cord compression; surgical decompression

Mesh:

Year:  2018        PMID: 30247981      PMCID: PMC6677247          DOI: 10.2214/AJR.18.19951

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  10 in total

1.  Delayed vertebral body collapse after stereotactic radiosurgery and radiofrequency ablation: Case report with histopathologic-MRI correlation.

Authors:  Adam N Wallace; Ross Vyhmeister; Andy C Hsi; Clifford G Robinson; Randy O Chang; Jack W Jennings
Journal:  Interv Neuroradiol       Date:  2015-10-23       Impact factor: 1.610

2.  Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial.

Authors:  Roy A Patchell; Phillip A Tibbs; William F Regine; Richard Payne; Stephen Saris; Richard J Kryscio; Mohammed Mohiuddin; Byron Young
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

3.  Osteoblastic bone lesions developing during treatment with erlotinib indicate major response in patients with non-small cell lung cancer: a brief report.

Authors:  Joline S W Lind; Pieter E Postmus; Egbert F Smit
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

Review 4.  A Novel Use of the Intraoperative MRI for Metastatic Spine Tumors: Laser Interstitial Thermal Therapy for Percutaneous Treatment of Epidural Metastatic Spine Disease.

Authors:  Jonathan G Thomas; Wajd N Al-Holou; Dhiego Chaves de Almeida Bastos; Amol J Ghia; Jing Li; Andrew J Bishop; Behrang Amini; Laurence D Rhines; Claudio E Tatsui
Journal:  Neurosurg Clin N Am       Date:  2017-08-19       Impact factor: 2.509

5.  Spine Cryoablation: Pain Palliation and Local Tumor Control for Vertebral Metastases.

Authors:  A Tomasian; A Wallace; B Northrup; T J Hillen; J W Jennings
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-01       Impact factor: 3.825

6.  [Remineralization and pain relief in bone metastases after after different radiotherapy fractions (10 times 3 Gy vs. 1 time 8 Gy). A prospective study].

Authors:  S Koswig; V Budach
Journal:  Strahlenther Onkol       Date:  1999-10       Impact factor: 3.621

7.  Osteoblastic response as a healing reaction to chemotherapy mimicking progressive disease in patients with small cell lung cancer.

Authors:  Joerg Stattaus; Steffen Hahn; Thomas Gauler; Wilfried Eberhardt; Stefan P Mueller; Michael Forsting; Susanne C Ladd
Journal:  Eur Radiol       Date:  2008-08-02       Impact factor: 5.315

8.  Spine Cryoablation: A Multimodality Image-Guided Approach for Tumors Adjacent to Major Neural Elements.

Authors:  J P Guenette; K Tuncali; N Himes; S Tatli; T C Lee
Journal:  AJNR Am J Neuroradiol       Date:  2016-09-08       Impact factor: 3.825

9.  Radiofrequency ablation combined with bone cement injection for the treatment of bone malignancies.

Authors:  Atsuhiro Nakatsuka; Koichiro Yamakado; Masayuki Maeda; Masayo Yasuda; Masao Akeboshi; Haruyuki Takaki; Ayumi Hamada; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2004-07       Impact factor: 3.464

Review 10.  Separation surgery for spinal metastases: effect of spinal radiosurgery on surgical treatment goals.

Authors:  Nelson Moussazadeh; Ilya Laufer; Yoshiya Yamada; Mark H Bilsky
Journal:  Cancer Control       Date:  2014-04       Impact factor: 3.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.